Total tumor volume predicts overall survival and response to induction chemotherapy in patients with colorectal cancer liver metastases: An ancillary study of the phase 3 CAIRO5 trial
J Michiel Zeeuw(Amsterdam Neuroscience), Geert Kazemier(Amsterdam Neuroscience), Marinde J. G. Bond(Utrecht University), Cornelis Verhoef(Erasmus MC Cancer Institute), Inez M. Verpalen(Amsterdam Neuroscience), John J. Hermans(Erasmus MC), Janneke E. van den Bergh(Dutch Cancer Society), Nina J. Wesdorp(Vrije Universiteit Amsterdam), J.H.T. van Waesberghe(Amsterdam Neuroscience), Rutger‐Jan Swijnenburg(Amsterdam University Medical Centers), Jaap Stoker(University of Amsterdam), Mike S.L. Liem(Medisch Spectrum Twente), Susan van Dieren(Amsterdam University Medical Centers), Shira Moos(Amsterdam Neuroscience), Mahsoem Ali(Vrije Universiteit Amsterdam), Gijs A. Patijn(Isala), Cornelis J.A. Punt(University of Amsterdam), Tineke E. Buffart(Amsterdam UMC Location Vrije Universiteit Amsterdam), Wouter K. G. Leclercq(Radboud University Nijmegen), Michael F. Gerhards(Radboud University Nijmegen), Joost Huiskens(Amsterdam UMC Location University of Amsterdam), Ruby Kemna(Vrije Universiteit Amsterdam), Joost M. Klaase(University Medical Center Groningen), Dirk J. Grünhagen(Erasmus MC), Arjen M. Rijken(Amphia Ziekenhuis), Joran Roor, I. Quintus Molenaar(Utrecht University), Thomas van Gulik, Martinus J. van Amerongen(Sint Maartenskliniek), Krijn P. van Lienden(St. Antonius Ziekenhuis), Theo Ruers(The Netherlands Cancer Institute), Ronald M van Dam(Maastricht University Medical Centre), Johannes HW de Wilt(Radboud University Nijmegen), Irene M G C Nota(Amsterdam Neuroscience), Marc R W Engelbrecht(Amsterdam University Medical Centers), Koert P. de Jong(University of Padua), Niels F.M. Kok(The Netherlands Cancer Institute), T. Chapelle(Antwerp University Hospital)
Cited by 3
Related Papers
Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target
|The American Journal of Gastroenterology|2015|1.8k
Direct detection of early-stage cancers using circulating tumor DNA
|Science Translational Medicine|2017|1.1k
Randomized Phase III Study of Panitumumab With Fluorouracil, Leucovorin, and Irinotecan (FOLFIRI) Compared With FOLFIRI Alone As Second-Line Treatment in Patients With Metastatic Colorectal Cancer
|Journal of Clinical Oncology|2010|1k
From tumour heterogeneity to advances in precision treatment of colorectal cancer
|Nature Reviews Clinical Oncology|2016|692